Notably, TLR4 plays a crucial role in M. tuberculosis infection (94) and TLR4 agonist have been developed as vaccine adjuvant candidate for TB to increase the efficacy of the existing vaccine (95); therefore, the vaccine models were subjected to molecular docking analysis with TLR4 in the normal mode. Here, TLR4 is linked to tuberculosis.